# FDA Inspection 1305066 - C5 Biomedical LLC - March 02, 2026

Source: https://www.keypedia.com/records/fda_inspections/c5-biomedical-llc/1a57a136-43b5-4456-a465-30a1a971fa44
Source feed: FDA_Inspections

> FDA Inspection 1305066 for C5 Biomedical LLC on March 02, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1305066
- Company Name: C5 Biomedical LLC
- Inspection Date: 2026-03-02
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Florida District Office

## Related Documents

- [FDA Inspection 1191632 - 2022-11-28](https://www.keypedia.com/records/fda_inspections/c5-biomedical-llc/85673e56-925e-4dd5-9e48-d341cfaed528)
- [FDA Inspection 1191632 - 2022-11-28](https://www.keypedia.com/records/fda_inspections/c5-biomedical-llc/0b587220-63ed-428b-aefc-34bf1b9276d9)

Company: https://www.keypedia.com/companies/c5-biomedical-llc/f66b3d37-079e-48d9-9fad-62ee2cd56c83

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9